A股異動丨金科文化(300459.SZ)反彈7% 湯姆貓IP系列動畫作品全球累計播放量超560億次
格隆匯9月11日丨近兩個交易日累跌逾21%的金科文化(300459.SZ)迎來反彈,現大漲7%,報4.58元,總市值162億元。金科文化在最新發布的《投資者關係活動記錄表》中透露,公司持續在推進“會説話的湯姆貓家族”IP大電影的相關工作,此前已與《刺客信條》製作人JeanJulienBaronne達成合作,目前已初步完成合作導演的洽談與確定。湯姆貓IP系列動畫作品全球累計播放量超560億次,此外,全新長篇動畫《會説話的湯姆貓家族》第五季作品在YouTube平台正式開播,動畫內容的推陳出新及播放渠道的開拓,將有助於公司持續擴大IP全球影響力。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.